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Randomised controlled trial of a
lay-led self-management
programme for Bangladeshi
patients with chronic disease
ABSTRACT
Background
Reducing the impact of chronic disease in minority
ethnic groups is an important public health challenge.
Lay-led education may overcome cultural and language
barriers that limit the effectiveness of professionally–led
programmes. We report the first randomised trial of a
lay-led self-management programme — the Chronic
Disease Self-Management Programme (CDSMP) (Expert
Patient Programme) — in a south Asian group.
Aim 
To determine the effectiveness of a culturally-adapted
lay–led self-management programme for Bangladeshi




Tower Hamlets, east London.
Method
We recruited Bangladeshi adults with diabetes,
cardiovascular disease, respiratory disease or arthritis
from general practices and randomised them to the
CDSMP or waiting-list control. Self-efficacy (primary
outcome), self-management behaviour, communication
with clinician, depression scores, and healthcare use
were assessed by blinded interviewer-administered
questionnaires in Sylheti before randomisation and
4 months later.
Results
Of the 1363 people invited, 476 (34%) agreed to take
part and 92% (439/476) of participants were followed
up. The programme improved self-efficacy (difference:
0.67, 95% confidence interval [CI] = 0.08 to 1.25) and
self-management behaviour (0.53; 95% CI = 0.01 to
1.06). In the 51% (121/238) of intervention participants
attending three or more of the 6-weekly education
sessions the programme led to greater improvements
in self-efficacy (1.47; 95% CI = 0.50 to 1.82) and self-
management behaviour (1.16; 95% CI = 0.50 to 1.82),
and reduced HADS depression scores (0.64; 95%
CI = 0.07 to 1.22). Communication and healthcare use
were not significantly different between groups. The
programme cost £123 (€181) per participant.
Conclusion
A culturally-adapted CDSMP improves self-efficacy and
self-care behaviour in Bangladeshi patients with chronic
disease. Effects on health status were marginal. Benefits
were limited by moderate uptake and attendance.
Keywords 
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INTRODUCTION
Minority ethnic groups often experience higher
morbidity and mortality than majority populations for a
range of chronic diseases.1 For example, compared
with the majority white population, people of South
Asian origin in the UK have a higher prevalence of
diabetes,2 are almost twice as likely to die from
cardiovascular disease,3 and have three times the
hospital admission rate for asthma.4 Ethnic diversity is
increasing in most industrialised countries. The need to
reduce inequalities in health outcomes between
majority and minority groups is widely recognised by
governments 5 and physician groups.6 Education
programmes that promote self-management of chronic
disease can reduce morbidity.7,8
Increasing ethnic diversity of populations means that
the development and evaluation of cultural adaptations
of such programmes are a priority. Minority ethnic
groups are often under-represented in trials of self-
management programmes9 and culturally adapted self-
management programmes are rare. Trials of self-
management education in populations of ethnic
diversity suggest that minority groups derive less
benefit than majority groups.10,11 Promoting
partnerships between empowered or ‘expert’ patients
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and physicians is seen as a fundamental part of
modern chronic disease management.12 Minority
ethnic groups may have difficulty establishing such
partnerships.13 Lay, or peer-led educational
programmes, notably the Chronic Disease Self-
management Programme (CDSMP),14 aim to promote
patient expertise and are becoming an established part
of chronic disease management in the US, Australia
and the UK, the latter as the UK Expert Patient
Programme.15 Culturally-adapted versions of lay-led
programmes have the potential to overcome cultural
and language barriers that may limit the effectiveness
of professionally-led educational programmes, but
have been tested only in Hispanic minority groups.16,17
The Bangladeshi community in the UK are a
marginalised ethnic group. They experience marked
socioeconomic deprivation, have poor access to care
and services and report the highest levels of chronic
disease of any ethnic group in the UK.18,19 We tested the
hypothesis that a culturally-adapted version of the
CDSMP (the Expert Patient Programme) would
improve the health of Bangladeshi patients with
diabetes, heart disease, respiratory disease or arthritis,
living in Tower Hamlets, east London. We report the
first randomised trial to test the benefit of any self-
management education programme for any South
Asian group and the first randomised trial to test the
effectiveness of the CDSMP in Europe.
METHOD
Participants
We recruited Bangladeshi adults (aged over 20 years)
with diabetes, arthritis, respiratory or cardiovascular
disease, by writing to people listed on disease registers
of 10 general practices serving large Bangladeshi
populations in Tower Hamlets. Letters were in English
as the Sylheti dialect has no commonly used written
form, but younger family members may read English.
Letters were followed by a telephone call by Sylheti-
speaking research assistants (one male, one female) to
ascertain interest in the study. Those interested in
taking part were invited to meet the research assistants
to learn more about the study. For cultural reasons the
researchers saw only participants of their own sex. If
they gave written informed consent to take part the
researcher recorded demographic data and carried out
a baseline study questionnaire.
Programme
The education programme was a culturally adapted
version of the CDSMP, a lay-led self-management
programme developed at Stanford University and
based on Bandura’s theoretical model of self-
efficacy.20,21 This sociocognitive theory proposes a
multifaceted model where an individuals’ beliefs about
self-efficacy operate with their goals and expectations
about outcome of their actions to influence self-care
behaviour. Self-efficacy has proved a reliable predictor
of behaviour change in studies of self-management.22 
Scales assessing self-efficacy have been translated
into at least 26 languages. Cross-cultural validity of
self-efficacy has been widely confirmed, although not
specifically in Syheti-speaking Bengalis.23 Self-efficacy
is a concept applicable to management of a wide
range of chronic diseases.14 Social Action for Health, a
local community group, adapted the CDSMP into the
Sylheti dialect and Islamic culture:
(http://www.ichs.qmul.ac.uk/research/gppc/respirator
y/adaption.html), omitting culturally inappropriate
topics such as instructions relating to power of
attorney (living wills). A supporting videocassette was
provided for participants in place of written material.
The programme comprised 6-weekly, 3-hour
sessions, and took place in general practices or
community centres. The six sessions covered topics
including symptom management, communication
with health professionals, managing medication,
exercise, and decision-making (Box 1). 
The programmes were led by pairs of trained and
accredited Bangladeshi lay tutors, who themselves
had chronic diseases (mainly diabetes), who acted
as facilitators. They used strategies including
mastering self-management skills, role-modelling
and reinterpretation of symptoms. Over a 2-year
period we ran seven programmes for men and eight
How this fits in
Reducing the impact of chronic disease in minority ethnic groups is an
important public health challenge. Culturally adapted, lay-led health education
may overcome barriers that limit the effectiveness of professionally-led
programmes. The impact of the CDSMP (Expert Patient Programme) in the UK
is unknown. A culturally-adapted, lay-led self-management education
programme improves self-efficacy, self-care behaviour and health status in
Bangladeshis with chronic disease. Benefits were limited by moderate uptake
and attendance. Effects on healthcare use and physiological and metabolic
markers of disease control are unclear.
Session 1: Course overview; acute and chronic conditions compared; 
cognitive symptom management; better breathing; introduction to 
action plans
Session 2: Feedback; dealing with anger, fear and frustration; introduction to 
exercise; making an action plan
Session 3: Feedback; distraction; muscle relaxation; fatigue management; 
monitoring exercise; making an action plan
Session 4: Feedback/making an action plan; healthy eating; communication 
skills; problem solving
Session 5: Feedback/making an action plan; medication usage; depression 
management; self-talk; treatment decisions; guided imagery
Session 6: Feedback; informing the healthcare team; working with your health 
care professional; looking forward
Box 1. Components of the Sylheti Adaptation of the Chronic
Disease Self Management Programme.
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allow for 10% loss to follow up. The study was
powered to detect a 40% standard deviation change
in self-efficacy with 80% power and 5% significance,
chosen because it was equivalent to an effect size
associated with improvements in behaviour, health
status and healthcare use found in trials of similar
programmes.14,29
Analysis
Our primary analysis was by intention to treat, blinded
to allocation. Since we expected limited attendance at
education sessions we also pre-specified a per-
protocol analysis, which included intervention group
participants who had attended three or more of the six
education sessions. All control group participants were
included in this analysis. We used STATA software to
analyse data using linear multiple regression for
continuous outcomes, proportional odds ordered
logistic regression for outcomes measured on Likert
scales, and poisson regression for health care use
Bangladeshi people from Tower Hamlets aged
30 years or over with chronic disease invited
to attend an appointment to find out about the
Chronic Disease Self-management




programme (n = 14)
No response (n = 453)
Incorrect address (n = 4)
Abroad (n = 4)
Ineligibility for 
programme (n = 18)
Declined (n = 37)
Unknown reason (n = 371)







---------------------------------- 4-month follow-up interview ---------------------------------
Primary outcome data










at 4 months (n = 218)
Figure 1. Participant flow.
Effectiveness of a lay-led
self-management
programme for
Bangladeshis in the UK
with chronic disease: A
randomised controlled
trial. 
programmes for women, with tutors of the
appropriate sex. We invited groups of about 25
intervention participants to each programme. 
Randomisation
The details of consenting participants were passed
to a researcher who randomised them using a
computer minimisation programme to attend the
education programme immediately or to a waiting list
control group. Randomisation was stratified by main
condition (diabetes, asthma, cardiovascular disease
or arthritis), age and sex.
Invitations and incentives to attend education
programme
Names and contact details of participants
randomised to the intervention groups were passed
to an administrator who sent written invitations by
post to participants with details of the venue and
times of sessions. To encourage attendance, we
offered transport to and from the venue by taxi, and
gave people who attended five or more sessions a
certificate of attendance and a supermarket voucher.
Outcomes questionnaire
The primary outcome was self-efficacy.20,24 Self-efficacy
was measured using six items (addressing general
condition management, distress, non-medication
management, discomfort, fatigue, and interference)
from the Chronic Disease Self-Efficacy Scale.25 Self-
management behaviour and communication with
physician were assessed using scales from the same
instrument, measuring use of cognitive symptom self-
management and communication strategies
respectively;25 health status was measured using: the
Hospital Anxiety and Depression Scale,26 5-point Likert
scales for pain, fatigue and breathlessness, and the
EuroQol EQ5D.27 Healthcare use and costs were
measured using six simple questions. We cross-
culturally adapted these scales using forward and back
translations with professional and lay bilingual (Sylheti
mother tongue) panels.28
The questionnaire was administered face to face to
participants by researchers before randomisation
and 4 months later, prior to the control group
receiving the programme. Interviewers were blinded
to treatment allocation. We decided against including
physiological measures such as serum measures of
glycaemic control or cholesterol since their inclusion
would compromise recruitment.
Study power
We needed at least 98 participants in each group to
complete the self-management programme (defined
as attending at least three of six sessions). We
increased the recruitment target to 108 per group, to
outcomes measured as number of visits. 
RESULTS
Characteristics of participants
Participant flow is given in Figure 1. Of 1349
Bangladeshi people approached by letter 462 (34%)
agreed to take part. A further 14 volunteered after
hearing about the programme by word of mouth or
local media. Participants allocated to the intervention
and control groups were well matched (Table 1). Three
hundred and twenty-five (68%) participants reported
diabetes as their main condition; 79 (17%)  asthma, 46
(10%) arthritis and 26 (5%) heart disease; 390 (82%)
had more than one condition. Despite a mean age of
49 years, only 8% were employed; education was
completed on average by 12 years of age.
Attendance at the education programme
One hundred and twenty-one (51%) of intervention
participants attended three or more of six sessions; 48
(20%) attended one or two sessions and 50 (21%)
attended none. Attenders and non-attenders did not
differ with respect to condition, sex, age, employment
or marital status.
Intervention group Control group
(n = 238) (n = 238)
Main chronic condition (%):
Diabetes 156 (66) 169 (71)
Asthma 46 (19) 33 (14)
Arthritis 22 (9) 24 (10)
Cardiovascular disease 14 (6) 12 (5)
Bangladeshi ethnicity 238 238
Mean age in years (SD) 48.9 (9.9) 48.0 (9.5)
Mean age in years when  12.2 (6.7) 12.4 (7.0)
education completed (SD)
Female sex (%) 133 (56) 139 (58)
In employment (%) 18 (8) 21 (9)
Marital status (%):
Married 204 (85) 208 (87)
Widowed 26 (11) 24 (10)
Single 4 (2) 2 (1)
Divorced 2 (1) 0 (0)
Separated 2 (1) 4 (2)
Table 1. Characteristics of participants in intervention and
control groups. 
Outcome Baseline 4 months Effect size (95% CI) P-value
Control Intervention Control Intervention
Self  efficacy 16.39 16.31 17.62 18.22 0.67a 0.025
(scale 5–30, ↑ better) (0.08 to 1.25)
Self care behaviour 7.16 7.23 8.31 8.95 0.53a 0.047
(scale 5–25, ↑ better) (0.01 to 1.06)
Communication with physician 6.68 6.49 7.49 7.60 0.15a 0.435
(scale 5–20, ↑ better) (-0.23 to 0.54)
Health status
Depression 8.64 8.84 8.49 8.55 -0.22a 0.392
(scale 0–21, ↓ better) (-0.71 to 0.28)
Anxiety 8.41 8.66 8.08 8.23 -0.09a 0.682
(scale 0–21, ↓ better) (-0.55 to 0.35)
Pain 3.49 3.36 3.23 3.07 -0.13b 0.462
(scale 1–5, ↓ better) (-0.48 to 0.22)
Fatigue 3.33 3.40 3.17 3.25 0.06b 0.721
(scale 1–5, ↓ better) (-0.22 to 0.12)
Shortness breath 2.29 2.45 2.23 2.26 -0.22b 0.249
(scale 1–5, ↓ better) (-0.60 to 0.16)
Health status 0.59 0.61 0.65 0.66 0.005a 0.827
EQ5D (-0.044 to 0.054)
Healthcare use
Visits to GP/practice nurse 4.12 3.97 3.71 3.53 0.99c 0.893
in last 3 months (0.90 to 1.10)
In all analyses, age, sex, main condition at baseline and baseline values of outcome are adjusted for. In the Poisson regression baseline value of outcome is
included as an offset. The coefficients presented are: aadjusted difference in means, bcoefficient on logistic scale, cincidence rate ratio. The coefficient on the
logistic scale presented for the proportional odds ordered logistic regression model is similar to the coefficient from a logistic regression model. For a logistic
model the coefficient can be directly converted to an easily interpretable odds ratio. This is not the case for the coefficients from the proportional odds ordered
logistic model. Negative coefficients for the proportional odds ordered model indicate that symptom scores are lower in the intervention group.
Table 2. Effect of education programme on primary and secondary outcomes: baseline and 4-month
values. Intention to treat analysis.
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Effect of the education programme
We obtained follow up data for 439/476 (92%) of
participants. Intention-to-treat analysis showed
improvements in self-efficacy with weak (P <0.05,
secondary outcome) evidence of improved self-
management behaviour in those randomised to
receive the education programme, compared to those
allocated to the waiting list (Table 2); other outcomes
were not significantly different between groups. Per-
protocol analysis (including intervention participants
attendance at three or more of six sessions) showed
similar improvements but of a greater magnitude, and
improved depression scores. Other outcomes were
not significantly different between groups (Table 2).
Characteristics of the participants from the
intervention group attending three or more sessions
were broadly similar to those attending fewer sessions
and those in the control group (Tables 1 and 3). 
In exploratory hypothesis-generating analyses, we
found no evidence of differences in effect by sex or
by condition (available from authors). These analyses
lacked statistical power.
Cost of the programme
Pairs of tutors were paid £587.10 (€865) per tutor to
facilitate each of the six week courses, making the
tuition costs £17 613 (€25 953) for the fifteen
intervention educational programmes. Similar costs
accrued for the control participants. Administration
costs were £20 400 (€30 060) per year over the two
year project — a total of £40 800 (€60 119),
comprising the salary of an administrator and
administrative costs. The total cost of the course was
thus £58 413 (€86 072). With 476 participants, the
cost of the programme was therefore £123 (€181)
per participant.
DISCUSSION
Summary of main findings
We found that Bangladeshi people with chronic
disease benefited from a 6-week chronic disease
self-management programme, delivered by trained
and accredited lay Bangladeshi tutors, who them-
selves had chronic disease. The programme
improved participants’ confidence (self-efficacy) to
control chronic disease and probably altered their
behaviour, increasing their use of self-management
skills. The combination of improved confidence and
altered self-care behaviour is important since both
are associated with better health outcomes.8
Recruitment and attendance of Bangladeshi
patients at education sessions was only moderate
despite providing incentives and support, and
compared poorly with that of other groups in
similar studies.14,16,30 We approached unselected
Bangladeshi patients directly in primary care. A third
of those approached agreed to take part and only
half of these attended three or more sessions. The
impact of the programme on people who attended
the majority of the education sessions is reflected by
the per-protocol analysis, where we found larger
changes in confidence and use of self-management
skills and improved depression scores, although
other measures of health status were unaltered.
Qualitative interviews with attenders and non-
attenders (reported elsewhere) suggest that there
were social and spiritual barriers to attendance.31
These included responsibilities relating to social roles
and health (care for family and guests, attending
other healthcare appointments), and views that
predetermination (‘takdir’ or destiny) of the Islamic
life-course made attendance futile.31 Initiatives to
improve attendance need to address these factors.
Strengths and limitations of the study
This is the first randomised trial to test the
effectiveness of any self-management educational
programme in a South Asian group, and the first to
test the effectiveness of the chronic disease self-
management programme in Europe. To date all data
on the CDSMP in Europe has either been anecdotal
or exploratory.32 Strengths of this study include: a
pragmatic design with adequate statistical power,
close involvement from the local Bangladeshi
community in the design and execution, concealed
treatment allocation, blinded outcome assessment
and analysis, and high rates of follow up. We chose
a relatively short (4-month) period of follow up since
the Bangladeshi population is highly mobile and we
considered that a long delay would discourage
Intervention group Control group
attending 0–2 sessions attending 3–6 sessions
(n = 116) (n = 238)
Main chronic condition (%)
Diabetes 60 (52) 86 (70)
Asthma 24 (21) 18 (15)
Arthritis 10 (9) 11 (9)
Cardiovascular disease 6 (5) 7 (6)
Mean age in years (SD) 43.8 (10.5) 48.5 (9.5)
Mean age in years when 12.1 (6.1) 12.3 (7.1)
education completed (SD)
Female sex (%) 52 (45) 59 (48)
In employment (%) 9 (8) 8 (7)
Marital status (%)
Married 91 (78) 98 (80)
Widowed 7 (6) 18 (15)
Single 2 (2) 2 (1.6)
Divorced 0 (0) 2 (1.6%)
Separated 0 (0) 2 (1.6%)
SD = standard deviation.
Table 3. Characteristics of participants the intervention
group who attended zero to two out of six sessions, and
who attended three to six out of six sessions.
participation in a waiting list control design.
Weaknesses include the lack of physiological
measures of disease control, short follow up, and
lack of quantitative assessment of validity of the
cross culturally adapted outcome scales.
Interpretation of clinical relevance of changes in
cross-culturally adapted scales is difficult,
particularly where constructs originate in Western
psychological or sociocognitive theory. Furthermore,
minimal important differences, if known, may not be
transferable. Some experts recommend de novo
development of scales. Although our preparatory
work included focus groups to determine needs of
local Bangladeshis, consideration of the relevance of
theoretical constructs of the intervention to the target
group, careful cross-cultural adaptation of the
intervention, and pilot work to assess feasibility and
usefulness of delivering the intervention, we did not
follow all steps recommended in the development of
a complex intervention.33
Comparison with existing literature
The magnitude of this improvement in self-efficacy
(roughly 10%) is similar to that seen in trials of the
chronic disease self-management programme in
other settings and populations.14,16,30 Unlike these
studies, we did not find changes in a wide range of
health status measures and health care use. This
may reflect a weaker effect of the intervention in
Bangladeshi people, lack of sensitivity in our
instruments or perhaps differences in the disease
characteristics of the trial populations — in our case
comprising few people with musculoskeletal or
respiratory conditions and over two-thirds with
diabetes. 
Despite high rates of primary care use at
recruitment we found no reduction in visit frequency
and no improvement in reported communication with
a physician. This is disappointing and suggests that
the programme may not impact on the
doctor–patient relationship in this group. Differences
in healthcare organisation and reimbursement
between the US and UK may underlie the differences
between the reductions seen in healthcare use seen
in evaluations in the US and our results. However,
decreased healthcare use is a highly debatable
outcome, particularly in communities with high
prevalence of chronic disease, and consequent
increased morbidity and mortality. Longer-term
assessments of healthcare use are needed. Low
Variable Baseline 4 months Effect size (95% CI) P-value
Control Intervention Control Intervention
Self-efficacy 16.39 16.42 17.62 18.96 1.47a <0.001
(scale 5–30, ↑ better) (0.76 to 2.20)
Self care behaviour 7.16 7.36 8.31 9.59 1.16a 0.047
(scale 5–25, ↑ better) (0.50 to 1.82)
Communication with physician 6.68 6.31 7.49 7.56 0.37a 0.112
(scale 5–20, ↑ better) (-0.09 to 0.83)
Health status
Depression 8.64 9.07 8.49 8.29 -0.64a 0.028
(scale 0–21, ↓ better) (-1.22 to -0.07)
Anxiety 8.41 8.58 8.08 8.24 -0.14a 0.724
(scale 0–21, ↓ better) (-0.89 to 0.62) 
Pain 3.49 3.32 3.23 3.03 -0.20b 0.360
(scale 1–5, ↓ better) (-0.44 to 0.40)
Fatigue 3.33 3.45 3.17 3.26 -0.02b 0.922
(scale 1–5, ↓ better) (-0.44 to 0.40)
Shortness breath 2.29 2.38 2.23 2.30 -0.22b 0.249
(scale 1–5, ↓ better) (-0.60 to 0.16)
Health status 0.59 0.61 0.65 0.66 0.009a 0.751
EQ5D (-0.05 to 0.069)
Healthcare use
Visits to GP/practice nurse 4.14 4.08 3.71 3.56 0.97c 0.625
in last 3 months (0.86 to 1.09)
In all analyses, age, sex, main condition at baseline and baseline values of outcome are adjusted for. In the poisson regression baseline value of outcome is
included as an offset. The coefficients presented are: aadjusted difference in means, bcoefficient on logistic scale, cincidence rate ratio. The coefficient on the
logistic scale presented for the proportional odds ordered logistic regression model is similar to the coefficient from a logistic regression model. For a logistic
model the coefficient can be directly converted to an easily interpretable odds ratio. This is not the case for the coefficients from the proportional odds ordered
logistic model. Negative coefficients for the proportional odds ordered model indicate that symptom scores are lower in the intervention group.
Table 4. Effect of education programme on primary and secondary outcomes: baseline and 4-month
values. Per protocol analysis — intervention participants attending at least three of six education
sessions and all control participants.
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attendance at the programme may reflect our
method of recruitment — directly approaching
patients in primary care practices — rather than
advertising for volunteers as used in other
studies.14,16,30 With only one-third of primary care
patients approached agreeing to join the programme
and poor attendance among some of those that did,
expectations of the benefits and in particular the cost
savings of the CDSMP for the NHS and its patients
may need to be tempered if these findings are
replicated in majority ethnic populations of the UK.
Implications for further research and clinical
practice
Our results give grounds for cautious optimism about
the benefits of such a programme in minority ethnic
groups in the UK, but also raise important questions
about the capacity of this programme which has
been promoted comprehensively across the NHS, to
deliver improved health status, reduced healthcare
use and costs which might justify taxpayers funds
committed to it. Further work should determine ways
of improving uptake, and longer-term impact of the
programme on health status, metabolic and
physiological outcomes, and healthcare use.
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